Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

TNXP

Tonix Pharmaceuticals (TNXP)

Tonix Pharmaceuticals Holding Corporation
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:TNXP
DateTimeSourceHeadlineSymbolCompany
07/16/20249:12AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:TNXPTonix Pharmaceuticals Holding Corporation
07/10/20244:48PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:TNXPTonix Pharmaceuticals Holding Corporation
07/10/20244:30PMGlobeNewswire Inc.Tonix Pharmaceuticals Announces Closing of $4.0 Million Public OfferingNASDAQ:TNXPTonix Pharmaceuticals Holding Corporation
07/09/20244:33PMEdgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:TNXPTonix Pharmaceuticals Holding Corporation
07/09/20249:15AMGlobeNewswire Inc.Tonix Pharmaceuticals Announces Pricing of Approximately $4.0 Million Public OfferingNASDAQ:TNXPTonix Pharmaceuticals Holding Corporation
07/08/20245:01PMEdgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:TNXPTonix Pharmaceuticals Holding Corporation
07/08/20245:00PMGlobeNewswire Inc.Tonix Pharmaceuticals Announces Proposed Public OfferingNASDAQ:TNXPTonix Pharmaceuticals Holding Corporation
07/08/20248:05AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:TNXPTonix Pharmaceuticals Holding Corporation
07/08/20248:00AMGlobeNewswire Inc.Tonix Pharmaceuticals Reports Final Positive Pre-NDA Meeting with FDA for Tonmyaâ„¢ for the Management of FibromyalgiaNASDAQ:TNXPTonix Pharmaceuticals Holding Corporation
07/01/20248:00AMGlobeNewswire Inc.Tonix Pharmaceuticals Awarded Up to $34 Million U.S. Department of Defense Contract for Accelerated Development of Broad-Spectrum Antiviral ProgramNASDAQ:TNXPTonix Pharmaceuticals Holding Corporation
06/28/20244:05PMGlobeNewswire Inc.Tonix Pharmaceuticals Announces Closing of $4.0 Million Public OfferingNASDAQ:TNXPTonix Pharmaceuticals Holding Corporation
06/27/20248:36AMGlobeNewswire Inc.Tonix Pharmaceuticals Announces Pricing of Approximately $4.0 Million Public OfferingNASDAQ:TNXPTonix Pharmaceuticals Holding Corporation
06/26/20244:40PMGlobeNewswire Inc.Tonix Pharmaceuticals Announces Proposed Public OfferingNASDAQ:TNXPTonix Pharmaceuticals Holding Corporation
06/26/20243:13PMGlobeNewswire Inc.Tonix Pharmaceuticals Regains Compliance with Nasdaq Minimum Bid Price RequirementNASDAQ:TNXPTonix Pharmaceuticals Holding Corporation
06/25/20248:00AMGlobeNewswire Inc.Tonix Pharmaceuticals Presents Vaccine Platform Data in Keynote Talk at the Vaccine Congress 2024NASDAQ:TNXPTonix Pharmaceuticals Holding Corporation
06/20/20248:05AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:TNXPTonix Pharmaceuticals Holding Corporation
06/20/20248:00AMGlobeNewswire Inc.Tonix Pharmaceuticals Announces Positive Pre-NDA CMC Meeting with FDA for Tonmyaâ„¢ for the Management of FibromyalgiaNASDAQ:TNXPTonix Pharmaceuticals Holding Corporation
06/18/20248:00AMGlobeNewswire Inc.Tonix Pharmaceuticals Presented Data Comparing Real-World Treatment of Migraine with Industry Guidelines for Non-Oral Products at the Annual Scientific Meeting of the American Headache Society (AHS)NASDAQ:TNXPTonix Pharmaceuticals Holding Corporation
06/17/20248:00AMGlobeNewswire Inc.Tonix Pharmaceuticals Presented Poster of Tonmyaâ„¢ for the Management of Fibromyalgia at the Annual European Congress of Rheumatology (EULAR) 2024NASDAQ:TNXPTonix Pharmaceuticals Holding Corporation
06/14/20245:25PMEdgar (US Regulatory)Form 8-K/A - Current report: [Amend]NASDAQ:TNXPTonix Pharmaceuticals Holding Corporation
06/13/20245:24PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:TNXPTonix Pharmaceuticals Holding Corporation
06/13/20245:00PMGlobeNewswire Inc.Tonix Pharmaceuticals Announces Closing of $4.0 Million Public OfferingNASDAQ:TNXPTonix Pharmaceuticals Holding Corporation
06/12/20245:01PMEdgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:TNXPTonix Pharmaceuticals Holding Corporation
06/12/20249:00AMGlobeNewswire Inc.Tonix Pharmaceuticals Announces Pricing of $4.0 Million Public OfferingNASDAQ:TNXPTonix Pharmaceuticals Holding Corporation
06/11/20245:17PMGlobeNewswire Inc.Tonix Pharmaceuticals Announces Proposed Public OfferingNASDAQ:TNXPTonix Pharmaceuticals Holding Corporation
06/11/20244:49PMEdgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:TNXPTonix Pharmaceuticals Holding Corporation
06/10/20248:53AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:TNXPTonix Pharmaceuticals Holding Corporation
06/06/202411:21AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:TNXPTonix Pharmaceuticals Holding Corporation
06/06/202411:00AMGlobeNewswire Inc.Tonix Pharmaceuticals Announces 1-for-32 Reverse Stock SplitNASDAQ:TNXPTonix Pharmaceuticals Holding Corporation
06/06/20248:05AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:TNXPTonix Pharmaceuticals Holding Corporation
 Showing the most relevant articles for your search:NASDAQ:TNXP